We are live on
!
Find out more
CAM
ClariVest Asset Management Portfolio holdings
AUM
$980M
1-Year Est. Return
60.89%
This Fund
S&P 500
This Quarter
Est. Return
+12.64%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$3B
AUM Growth
+$175M
(+6.2%)
Cap. Flow
-$110M
Cap. Flow
% of AUM
-3.66%
Top 10 Holdings %
Top 10 Hldgs %
32.91%
Holding
863
New
116
Increased
124
Reduced
210
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$14.6M |
| 2 |
Olin
OLN
|
+$13.5M |
| 3 |
Dick's Sporting Goods
DKS
|
+$12.1M |
| 4 |
Old Dominion Freight Line
ODFL
|
+$9.78M |
| 5 |
Darden Restaurants
DRI
|
+$9.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$25.1M |
| 2 |
Eli Lilly
LLY
|
+$17M |
| 3 |
Procter & Gamble
PG
|
+$14.3M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$11.5M |
| 5 |
eBay
EBAY
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.15% |
| 2 | Consumer Discretionary | 18.06% |
| 3 | Healthcare | 13.51% |
| 4 | Communication Services | 9.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Walker & Dunlop
WD
$1.54B
| $2.59M | 0.09% |
24,784
-200
| -0.8% | -$20.9K |
|
202
Pool Corp
POOL
$7.51B
| $2.56M | 0.09% |
5,590
-5,000
| -47% | -$2.11M |
|
203
BlueLinx
BXC
$694M
| $2.43M | 0.08% |
+48,300
| New | +$2.38M |
|
204
Fortune Brands Innovations
FBIN
$6.06B
| $2.43M | 0.08% |
28,513
-46,332
| -62% | -$4.05M |
|
205
Cognex
CGNX
$11.5B
| $2.39M | 0.08% |
28,400
| – | – |
|
|
HIMX
206
Himax Technologies
HIMX
$2.54B
| $2.38M | 0.08% |
143,224
+142,300
| +15,400% | +$1.88M |
|
207
Astrana Health
ASTH
$1.76B
| $2.3M | 0.08% |
36,584
+36,521
| +57,970% | +$1.35M |
|
208
Boston Beer
SAM
$1.92B
| $2.25M | 0.07% |
2,200
| – | – |
|
209
Community Health Systems
CYH
$426M
| $2.23M | 0.07% |
144,641
+58,194
| +67% | +$791K |
|
210
Westamerica Bancorp
WABC
$1.38B
| $2.23M | 0.07% |
38,437
-200
| -0.5% | -$12.5K |
|
|
CDMO
211
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.2M | 0.07% |
85,595
-26,409
| -24% | -$564K |
|
212
Ichor Holdings
ICHR
$2.49B
| $2.14M | 0.07% |
39,696
+13,099
| +49% | +$721K |
|
213
Neurocrine Biosciences
NBIX
$16.7B
| $2.12M | 0.07% |
21,760
| – | – |
|
214
AngloGold Ashanti
AU
$49.1B
| $2.11M | 0.07% |
113,400
| – | – |
|
215
TD Synnex
SNX
$20.3B
| $2.06M | 0.07% |
16,879
-13
| -0.1% | -$1.6K |
|
|
DRNA
216
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.03M | 0.07% |
54,487
+58
| +0.1% | +$1.78K |
|
|
JHG
217
DELISTED
Janus Henderson
JHG
| $1.96M | 0.07% |
50,409
+119
| +0.2% | +$4.33K |
|
218
Coca-Cola Europacific Partners
CCEP
$47.5B
| $1.94M | 0.06% |
32,764
+18,915
| +137% | +$1.1M |
|
219
Yeti Holdings
YETI
$3.98B
| $1.92M | 0.06% |
20,918
-3,761
| -15% | -$327K |
|
220
Applied Industrial Technologies
AIT
$13.3B
| $1.89M | 0.06% |
20,777
-300
| -1% | -$28.6K |
|
|
SAGE
221
DELISTED
Sage Therapeutics
SAGE
| $1.85M | 0.06% |
+32,500
| New | +$2.3M |
|
|
EFOR
222
Everforth Inc
EFOR
$1.32B
| $1.84M | 0.06% |
18,949
+44
| +0.2% | +$4.5K |
|
223
Wipro
WIT
$19.8B
| $1.78M | 0.06% |
455,000
| – | – |
|
|
PCH
224
DELISTED
PotlatchDeltic
PCH
| $1.77M | 0.06% |
33,339
+24,497
| +277% | +$1.41M |
|
225
iShares MSCI India ETF
INDA
$6.63B
| $1.75M | 0.06% |
39,500
| – | – |
|
Similar funds
GCAC
D
PP
FTIS
AIA
SEC
AFG
ECM
ClariVest Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, ClariVest Asset Management held 863 positions worth $3B, up 6.2% from $2.83B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
ClariVest Asset Management withdrew a net $110M in Q2 2021, closing 111 positions and reducing 210 holdings. Its most notable exit was Amgen, an estimated $25.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, ClariVest Asset Management opened a new position in Charles Schwab worth $15M.
- ClariVest Asset Management's largest Q2 2021 buy was Charles Schwab: 206,235 shares worth $15M.
- ClariVest Asset Management added most to Olin in Q2 2021, an estimated $13.5M increase.
- ClariVest Asset Management's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $17M.
- ClariVest Asset Management fully exited Amgen in Q2 2021, selling an estimated $25.1M.
- ClariVest Asset Management's ten largest holdings make up 33% of its $3B portfolio in Q2 2021.
- ClariVest Asset Management opened 116 new positions and closed 111 in Q2 2021.
- ClariVest Asset Management's portfolio value rose 6.2% quarter-over-quarter to $3B.
Based on ClariVest Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.